Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Robert J. Kammer currently holds 797,327 shares of Imprimis Pharmaceuticals, Inc. (IMMY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert J. Kammer has been a net seller of IMMY stock. They have purchased $0 and sold $1.1M worth of shares.
Robert J. Kammer's most recent insider trade was on Nov 11, 2019, when they sold 6,500 shares at $4.75 per share.
Robert J. Kammer serves as Executive at Imprimis Pharmaceuticals, Inc. (IMMY). They have executed 34 insider transactions totaling $1.1M over their tenure at the company.
Robert J. Kammer holds the position of Executive at Imprimis Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 14 years and currently hold a stake valued at $0.
Robert J. Kammer has shown a selling trading pattern, with $0 in total purchases and $1.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Robert J. Kammer was on Nov 2, 2016, when they sold $435.1K worth of IMMY shares. This transaction involved 95,000 shares at $4.58 per share.
Robert J. Kammer currently owns 797,327 shares of Imprimis Pharmaceuticals, Inc. (IMMY), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Robert J. Kammer's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Robert J. Kammer has 34 Form 4 filings on record as an insider at Imprimis Pharmaceuticals, Inc..
Set alerts for Robert J. Kammer and 40,000+ other insiders.